Patent details

Basic Information

Publication number:

EP3235812

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP171603863

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

DEUTERATED DERIVATIVES OF IVACAFTOR

French Title of Invention:

DÉRIVÉS DEUTÉRÉS D'IVACAFTOR

German Title of Invention:

DEUTERIERTE IVACAFTOR-DERIVATE

SPC Number:

Dates

Filing date:

17/05/2012

Grant date:

04/09/2019

EP Publication Date:

25/10/2017

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

04/09/2019

EP B1 Publication Date:

04/09/2019

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

17/05/2032

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

28/08/2019

 

 

Name:

Vertex Pharmaceuticals (Europe) Limited

Address:

2 Kingdom Street, London W2 6BD, United Kingdom (GB)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

15/11/2019

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

Name:

Morgan,, Adam J

Address:

United States (US)

Priority

Priority Number:

201161487497 P

Priority Date:

18/05/2011

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/47; A61P 11/12; C07B 59/00; C07D 215/56;

Publication

European Patent Bulletin

Issue number:

201936

Publication date:

04/09/2019

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

01/06/2026

Annual Fee Number:

15

Annual Fee Amount:

213 Euro

Expected Payer:

Last Annual Fee Payment Date:

27/05/2025

Last Annual Fee Paid Number:

14

Last Annual Fee Paid Amount:

198 Euro

Payer:

Computer Packages INC

Filing date	Document type	Number of pages
15/11/2019	Power Of Attorney	1
21/11/2019	Outgoing Correspondence	1